AbbVie
ABBV
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products incudes Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
MarketBeat • 1 day ago • ABBV
The Most Important Part of These 3 Big Pharma Earnings Reports Wasn't the Beat
Wall Street Journal • 2 days ago • ABBV
AbbVie's Earnings Beat Wall Street's Estimates. Investors Are Still Worried
Seeking Alpha • 3 days ago • ABBV
AbbVie: Balancing Potential Acquisition Impact With Positive Q1 2026 Earnings
GlobeNewsWire • 3 days ago • ABBV
AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec
24/7 Wall Street • 3 days ago • ABBV
Price Prediction: Why AbbVie's Post-Humira Pivot Makes It a Strong Buy
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.